KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Inventory (2017 - 2025)

Historic Inventory for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to $90.5 million.

  • Guardant Health's Inventory rose 2516.11% to $90.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $90.5 million, marking a year-over-year increase of 2516.11%. This contributed to the annual value of $71.1 million for FY2024, which is 1474.62% up from last year.
  • Per Guardant Health's latest filing, its Inventory stood at $90.5 million for Q3 2025, which was up 2516.11% from $84.1 million recorded in Q2 2025.
  • In the past 5 years, Guardant Health's Inventory ranged from a high of $90.5 million in Q3 2025 and a low of $24.7 million during Q3 2021
  • Its 5-year average for Inventory is $57.5 million, with a median of $61.9 million in 2023.
  • In the last 5 years, Guardant Health's Inventory crashed by 1078.94% in 2021 and then soared by 15484.86% in 2022.
  • Quarter analysis of 5 years shows Guardant Health's Inventory stood at $30.7 million in 2021, then surged by 68.21% to $51.6 million in 2022, then grew by 20.06% to $61.9 million in 2023, then increased by 14.75% to $71.1 million in 2024, then grew by 27.3% to $90.5 million in 2025.
  • Its last three reported values are $90.5 million in Q3 2025, $84.1 million for Q2 2025, and $77.3 million during Q1 2025.